Renin in essential hypertension.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000367:Age Factors; D000450:Aldosterone / Q000097:blood; D000804:Angiotensin II; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002216:Captopril / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000401:mortality; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D011187:Posture; D011945:Receptors, Angiotensin / Q000378:metabolism; D012083:Renin / Q000097:blood*; D012084:Renin-Angiotensin System / Q000187:drug effects; D012504:Saralasin; D012964:Sodium / Q000652:urine
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D011945:Receptors, Angiotensin; D000804:Angiotensin II; D000450:Aldosterone; D002216:Captopril; D012964:Sodium; D012083:Renin; D012504:Saralasin